Bladder cancer is three times more common in men than women¹. If there is a history of recurrent idiopathic hematuria (blood in urine) or bladder cancer with your patient, GenPath offers testing that can aid in diagnosis and monitoring of bladder cancer.
|Test Code||Test Name|
|5030-2||UroVysion® – Bladder Cancer (FISH), voided urine|
|5324-9||Comprehensive Urine Pathology (Urine Cytology and UroVysion)|
|TF89-0||hTERT (Human Telomerase Reverse Transcriptase)|
- American Society of Clinical Oncology. https://www.cancer.net/cancer-types/kidney-cancer/risk-factors-and-prevention. Accessed May 22, 2019.